Hemovigilance in the United States of America
Hemovigilance in the United States of America
复制标题
美利坚合众国的血液警戒
DOI：
10.1111/j.1423-0410.1998.tb05455.x
复制
发表时间：
1998
期刊：
影响因子：
2.7
通讯作者：
J. Menitove
中科院分区：
文献类型：
--
作者：
J. Menitove
尽管血液警戒在美国并不是一个常用的词，但监测与输血相关的发病率的概念被广泛接受。目前，在血库的“制造”和“临床”方面，质量管理侧重于避免差错，而不是差错检测。“制造”主要由现行的良好制造规范管理，而临床输血药物则遵循临床实践指南。政府、专业和非营利性监管机构之间存在多个重叠的质量保证和错误报告机制。每一项战略都强调对防止错误的系统方法的持续需要。
Although hemovigilance is not a word used commonly in the United States, the concept of monitoring morbidity associated with blood transfusion is accepted widely. Currently, quality management focuses on error avoidance rather than error detection in both the “manufacturing” and “clinical” aspects of blood banking. “Manufacturing” is regulated predominantly by current Good Manufacturing Practices while clinical transfusion medicine follows clinical practice guidelines. There are multiple overlapping mechanisms for quality assurance and error reporting among governmental, professional, and non‐profit regulatory agencies. The strategies of each stress the on‐going need for a systems approaches to preventing errors.
血小板减少白细胞和紫外线 B 照射，以防止同种免疫和血小板输注无效。
DOI：
10.1056/nejm199712253372601
发表时间：
1997
期刊：
The New England journal of medicine
影响因子：
--
作者：
TrialtoReduceAlloimmunizationtoPlateletsStudyGroup
通讯作者：
TrialtoReduceAlloimmunizationtoPlateletsStudyGroup